InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Introduction: Financing through understanding


IP's intangible nature does little to bolster investor confidence in biotechnology. Roya Ghafele, who works as an economist at WIPO, says that biotechnology is insufficiently funded due to a lack of awareness of the value of patents among both borrowers and investors

Intangibles such as patents have historically been treated as if they were invisible, and irrelevant to individual business performance. So capital markets tended to punish research-intensive companies, which are common in biotechnology.

New growth theory explains that economic growth is...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null null null

nullnullnull

null

March / April 2019

IP counsel reflect on gender challenges and progress

In a special feature to celebrate International Women’s Day on March 8, Ellie Mertens speaks to counsel at Uber, Xerox, Micron and others about women in IP – the progress and the path



Most read articles

Supplements